Intuitive Surgical (IUI1) Price & Analysis

40 Followers

IUI1 Stock Chart & Stats

€320.35

-€7.60(-2.37%)

At close: Jul 29 4:00 PM EDT

€320.35

-€7.60(-2.37%)

Day’s Range― - ―

52-Week Range€290.45 - €516.10

Previous CloseN/A

Volume498.00

Average Volume (3M)425.00

Market Cap

€134.23B

Enterprise Value€136.97B

Total Cash (Recent Filing)€5.22B

Total Debt (Recent Filing)€0.00

Price to Earnings (P/E)48.2

Beta0.64

Next Earnings

Oct 20, 2026

EPS Estimate

2.36

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)8.85

Shares Outstanding353,278,050

10 Day Avg. Volume540

30 Day Avg. Volume425

Financial Highlights & Ratios

PEG Ratio3.17

Price to Book (P/B)11.34

Price to Sales (P/S)20.08

P/FCF Ratio81.16

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€435.74

Price Target Upside36.02% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering17

EPS Forecast (FY)9.62

Revenue Forecast (FY)€10.47B

Bulls Say, Bears Say

Bulls Say

Recurring Revenue ModelThe large recurring-revenue base ties sales to procedure volumes, instrument replenishment, and service contracts rather than relying solely on infrequent system purchases. This supports visibility, customer retention, and durable monetization of the expanding installed base over the next several quarters.

Installed Base ExpansionExpansion of the installed base increases future procedure capacity and creates a larger pool for recurring instruments, accessories, and service revenue. Continued growth across hospitals and surgical centers also strengthens Intuitive’s ecosystem and reinforces adoption across specialties.

Cash Generation And MarginsStrong cash generation combined with high gross margins gives Intuitive substantial capacity to fund research, training, commercial expansion, and shareholder returns internally. The company’s minimal leverage further preserves flexibility to invest through changing procedure and capital-spending conditions.

Bears Say

China Market PressureWeak tender activity and local competition can constrain system placements and pricing in China, limiting growth from an important international market. The lack of da Vinci 5 clearance there may also delay product-cycle momentum and leave the business exposed to ongoing policy-driven pressure.

Moderating U.S. Procedure GrowthSlower U.S. procedure growth could reduce the pace of recurring instrument revenue and system utilization, particularly where benign procedures are deferrable. Uncertainty around patient coverage and the timing of a return to care creates execution risk against the company’s growth outlook.

Extended-Use Instrument RiskIf extended-use instruments reduce replacement frequency, they could weaken instruments-and-accessories revenue per procedure even as procedure volumes grow. That would pressure the economics of Intuitive’s razor-and-blades model and make recurring revenue growth more dependent on utilization.

Intuitive Surgical News

Intuitive Surgical price target raised to $415 from $400 at Mizuho

Mizuho raised the firm’s price target on Intuitive Surgical (ISRG) to $415 from $400 and keeps a Neutral...

7d ago

ISRG

Intuitive Surgical price target lowered to $454 from $469 at BTIG

BTIG lowered the firm’s price target on Intuitive Surgical (ISRG) to $454 from $469 and keeps a Buy...

7d ago

ISRG

Flutter upgraded, AppFolio downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

12d ago

Intuitive Surgical initiated with an Overweight at Barclays

Barclays initiated coverage of Intuitive Surgical (ISRG) with an Overweight rating and $485 price target The firm rolled...

13d ago

ISRG

Private Markets: Instinct leads week’s private raises with $1B

Private company fundraising this week was led by Instinct’s $1B round and notable capital injections into edge AI,...

18d ago

Intuitive Surgical: Analyst Maintains Buy on Robust Robotic Demand and Attractive Upside vs. Conservative Forecasts

Analyst Joshua Buchalter of TD Cowen maintained a Buy rating on Intuitive Surgical, with a price target of...

8h ago

ISRG

Intuitive Surgical (ISRG) Q3 Earnings Cheat Sheet

Intuitive Surgical (ISRG) is scheduled to report 3rd quarter earnings on 10/20/2026. Regarding Q3 estimates, Wall Street analysts...

2d ago

ISRG

Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway; Price Target Maintained at $500

In a report released today, Patrick Wood from UBS maintained a Buy rating on Intuitive Surgical, with a...

7d ago

ISRG

Overvalued Healthcare Stocks? Analysts See Upside in These 3 High P/E Names

Using the TipRanks Stock Screener tool, we identified three Healthcare stocks with P/E ratios ranging from 39.58x to 43.34x, Strong Buy...

1M ago

ALNY

BTSG

3 Healthcare Stocks with More Than 20% Upside and Recent Buy Ratings

Eli Lilly ($LLY), UnitedHealth Group ($UNH), and Intuitive Surgical ($ISRG) have each received Buy ratings from Wall Street...

1M ago

LLY

UNH

Healthcare Costs Are Rising Twice as Fast as Everything Else: Inside Milliman’s Healthcare Inflation ETFs (MHIG, MHIP)

U.S. healthcare costs are climbing more than 7% a year, over double broad inflation, and most portfolios hold...

1M ago

JNJ

LLY

SS Innovations International (NASDAQ: SSII) Highlighted as Stronger Growth Opportunity in Seeking Alpha Analysis

Austin, Texas, United States, September 2nd, 2026, FinanceWire SS Innovations International (NASDAQ:SSII) was highlighted in a Seeking Alpha analysis...

2M ago

ISRG

SSII

Trump Trade: Canada rolls out 50% tariffs on U.S. metals

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

2M ago

HHS plans to add FDA deputy roles for technology, drugs, CNBC says

The Department of Health and Human Services is planning to create two new deputy commissioner roles at the...

2M ago

ABT

BMY

IUI1 FAQ

What was Intuitive Surgical’s price range in the past 12 months?

Intuitive Surgical lowest stock price was €290.45 and its highest was €516.10 in the past 12 months.

What is Intuitive Surgical’s market cap?

Intuitive Surgical’s market cap is €134.23B.

When is Intuitive Surgical’s upcoming earnings report date?

Intuitive Surgical’s upcoming earnings report date is Oct 20, 2026 which is tomorrow.

How were Intuitive Surgical’s earnings last quarter?

Intuitive Surgical released its earnings results on Jul 16, 2026. The company reported €2.493 earnings per share for the quarter, beating the consensus estimate of €2.236 by €0.257.

Is Intuitive Surgical overvalued?

According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Intuitive Surgical pay dividends?

Intuitive Surgical does not currently pay dividends.

What is Intuitive Surgical’s EPS estimate?

Intuitive Surgical’s EPS estimate is 2.36.

How many shares outstanding does Intuitive Surgical have?

Intuitive Surgical has 353,278,050 shares outstanding.

What happened to Intuitive Surgical’s price movement after its last earnings report?

Intuitive Surgical reported an EPS of €2.493 in its last earnings report, beating expectations of €2.236. Following the earnings report the stock price went down -12.252%.

Which hedge fund is a major shareholder of Intuitive Surgical?

Currently, no hedge funds are holding shares in DE:IUI1

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Intuitive Surgical Stock Smart Score

Outperform

Fundamentals

Return on Equity

17.83%

Trailing 12-Months

Asset Growth

3.54%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Intuitive Surgical

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Intuitive Surgical (IUI1) Earnings & Revenues

Historic Earnings Reports

IUI1 Company Deck

IUI1 Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call presented a predominantly positive operational and financial picture: robust revenue (+19%), strong profitability (42% non-GAAP operating margin), healthy procedure growth (total +16%) and capital placements (468 da Vinci systems), plus strong cash flow. The company also highlighted meaningful product progress (da Vinci 5 updates, SP and XiR momentum, ION adoption) and clinical evidence supporting adoption. Key risks were noted but were mostly market- and policy-driven (U.S. patient coverage dynamics, China tender and pricing pressure), some procedure-mix headwinds (bariatrics) and an unquantified impact from the extended-use instrument program. Overall, the positive metrics and growth drivers materially outweigh the challenges discussed.View all DE:IUI1 earnings summaries

IUI1 Revenue Breakdown

67.72% U.S.

32.28% Outside of U.S

IUI1 Stock 12 Month Forecast

Average Price Target

€435.74

▲(36.02% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"304":"€304","457":"€457","610":"€610","380.5":"€380.5","533.5":"€533.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":609.97925895,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€609.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":435.74187452,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€435.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":348.17794197,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€348.18</span>\n  </div></div>","useHTML":true}}],"tickPositions":[304,380.5,457,533.5,610],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,360.1,379.32148145769236,398.54296291538463,417.76444437307697,436.98592583076925,456.2074072884616,475.4288887461539,494.6503702038462,513.8718516615385,533.0933331192308,552.3148145769231,571.5362960346154,590.7577774923077,{"y":609.97925895,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,360.1,365.9186057323077,371.7372114646154,377.5558171969231,383.3744229292308,389.1930286615385,395.0116343938462,400.83024012615385,406.6488458584615,412.46745159076926,418.28605732307693,424.10466305538466,429.92326878769234,{"y":435.74187452,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,360.1,359.18291861307694,358.26583722615385,357.34875583923076,356.43167445230773,355.51459306538464,354.59751167846156,353.68043029153847,352.7633489046154,351.8462675176923,350.92918613076927,350.0121047438462,349.0950233569231,{"y":348.17794197,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":369.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":462.35,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":491,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":489.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.25,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":386.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":361.25,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":318.1,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.1,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >